## Diagnosis: P. vivax Relapse from Hypnozoites ### Understanding Hypnozoites and Relapse **Key Point:** P. vivax and P. ovale possess hypnozoites — dormant forms in the liver that can persist for months to years and cause relapses even after successful treatment of the acute erythrocytic infection. **High-Yield:** Relapse in P. vivax malaria occurs because: 1. Hypnozoites are refractory to most antimalarials (except primaquine and tafenoquine). 2. They remain dormant in hepatocytes and periodically activate, releasing merozoites into the bloodstream. 3. Relapse typically occurs 3–12 months after the initial infection (this patient: 6 months). ### Hypnozoite vs. Other Recurrence Patterns | Feature | Relapse (Hypnozoites) | Recrudescence | Reinfection | |---------|----------------------|---------------|-------------| | **Parasite source** | Liver (dormant forms) | Blood (persistent parasites) | New mosquito exposure | | **Species** | P. vivax, P. ovale | P. falciparum, P. malariae | Any species | | **Timing** | Weeks to months/years | Days to weeks | Variable | | **Trigger** | Immune suppression, stress | Drug resistance, inadequate dosing | New exposure | | **Prevention** | Primaquine (8-aminoquinoline) | Adequate dosing, drug sensitivity | Vector control | ### Life Cycle: Where Hypnozoites Hide ```mermaid flowchart TD A[Mosquito bite: Sporozoites inoculated]:::outcome --> B[Liver: Pre-erythrocytic stage]:::action B --> C{P. vivax/ovale?}:::decision C -->|Yes| D[Some sporozoites → Hypnozoites]:::action C -->|No| E[All sporozoites → Schizonts]:::action D --> F[Dormant in hepatocytes for months/years]:::action E --> G[Immediate schizogony, release merozoites]:::action F --> H[Periodic activation → Merozoite release]:::action H --> I[Erythrocytic infection: Fever relapse]:::outcome G --> J[Erythrocytic infection: Acute malaria]:::outcome ``` ### Why RDT Remains Positive **Clinical Pearl:** The RDT detects P. vivax antigens (HRP-2, pLDH) that persist in the bloodstream during relapse. A positive RDT 6 months post-treatment is highly suggestive of relapse, not reinfection (which would typically show a negative RDT after successful treatment and clearance). ### Treatment of Relapse **Mnemonic:** **PRIMO = PRImaquine for Malaria Ovale and vivax** — primaquine is the only drug that reliably eliminates hypnozoites by targeting the liver stage. - **Standard regimen:** Primaquine 0.5 mg/kg/day for 14 days (after acute phase treatment with chloroquine or artemisinin derivatives). - **G6PD screening:** Essential before primaquine use due to risk of hemolysis in G6PD-deficient patients. - **Alternative:** Tafenoquine (single dose) is a newer 8-aminoquinoline with longer half-life. [cite:Park 26e Ch 3; Harrison 21e Ch 218] 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.